Generic drug company Apotex has settled a patent infringement case brought by global pharmaceutical giant Lundbeck over its blockbuster antidepressant Lexapro.
ASIC has successfully opposed a Federal Court judge’s push to appoint an independent referee in its case against AMP Financial Planning over alleged insurance churning.
The High Court has dismissed the ACCC’s bid to appeal a Full Federal Court decision upholding a ruling that drug giant Pfizer did not misuse its market power in the months leading up to the expiration of the patent for its blockbuster cholesterol drug Lipitor.
PriceWaterHouse Coopers has received the green light to launch court action to pursue its cross claims against failed educational training company Vocation.
The Commonwealth of Australia has resolved its claims against pharmaceutical giant Wyeth over the price it paid to list Effexor on the PBS, months after a high stakes trial wrapped up.
Medical device maker American Medical Systems, which is facing a class action over allegedly faulty pelvic mesh implants, has taken a page from the Ethicon pelvic mesh defence playbook, calling on the court to restrict the dates for group membership.
Senator Sarah Hanson-Young has accused Senator David Leyonhjelm of using parliamentary privilege and fabricated remarks to shut down a defamation case she lodged in August.
Liquidators for Dick Smith don’t want potential group members in two class actions against the failed retailer to learn about a new registration deadline by email, saying it would amount to spam and harassment.
A Federal Court judge has stayed a $2.6 million award against QBE Insurance (Australia) to cover losses related to the 2014 collapse of steel product manufacturer Independent Tube Mills in 2014.
A federal judge has lit a fire under the law firm leading the Westpac life insurance class action, saying if it wanted to apply for a stay while the bank appeals his common fund order, it should do so “immediately”.